Cargando…
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia
Thrombosis in patients with thrombocytopenia has several risk factors, both disease-related and treatment-associated. Recently, COVID-19 infection was recognized as an additional risk factor, further complicating the delicate balance between thrombosis and bleeding in these patients. Here we describ...
Autores principales: | Alessandro, Bosi, Wilma, Barcellini, Bruno, Fattizzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398496/ https://www.ncbi.nlm.nih.gov/pubmed/35999631 http://dx.doi.org/10.1186/s12959-022-00407-w |
Ejemplares similares
-
Correction: Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia
por: Bosi, Alessandro, et al.
Publicado: (2022) -
Childhood aplastic anaemia with paroxysmal nocturnal haemoglobinuria clones: A retrospective single-centre study in South Africa
por: Hendricks, Candice L., et al.
Publicado: (2022) -
COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria
por: Pike, Alexandra, et al.
Publicado: (2022) -
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2021) -
Ravulizumab for paroxysmal nocturnal haemoglobinuria
Publicado: (2022)